search

Active clinical trials for "Hypertension"

Results 3261-3270 of 5863

Home Blood Pressure Monitoring Project

Hypertension

The goal of this project is to improve hypertension control at Kaiser Permanente Colorado (KPCO) by implementing a population-based multi-factorial intervention that uses home BP monitors that can download BP readings to KPCO's health records via internet, interactive voice response (IVR) technology, and multidisciplinary care team. Participants will be randomized to either the home blood pressure monitoring group receiving the multi-factorial intervention or the usual care group who will be receiving Kaiser standard of care. We will determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines. The study hypothesis is that a higher proportion of patients with uncontrolled hypertension in the home blood pressure monitoring (HBPM) group will achieve their target blood pressure compared to those in the usual care (UC) group.

Completed12 enrollment criteria

Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers

Hypertension

Assess mechanism of action of LCZ696 related to sodium excretion.

Completed6 enrollment criteria

A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)

Hypertension

This study will determine if MK-3614, given as single doses, is safe and well tolerated in healthy males and male participants with mild to moderate hypertension.

Completed10 enrollment criteria

Effects of Anthocyans on Cardiovascular and Sympathetic Function

Hypertension

Anthocyans modify cardiovascular and sympathetic function

Completed3 enrollment criteria

VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria...

Hypertension

The purpose of this study is to compare if the combination of valsartan 320 mg/lisinopril 20 mg versus the monotherapies of lisinopril 40 mg or valsartan 320 mg will result in a greater decrease of urinary albumin excretion measured as urinary albumin/creatinine ratio (UACR) in the first morning urine of hypertensive subjects with previously diagnosed microalbuminuria (MAU).

Completed11 enrollment criteria

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension...

Hypertension

This is a double-blind study to evaluate the reduction in systolic blood pressure using a therapy initiated with valsartan 160 mg or valsartan + hydrochlorothiazide (HCTZ) 160/12.5 mg compared to a more conventional approach (therapy initiated with low-dose valsartan 80 mg).

Completed6 enrollment criteria

Improving Adherence to Blood Pressure Guidelines

Hypertension

The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.

Completed13 enrollment criteria

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

Open Angle GlaucomaOcular Hypertension

The purpose of this study is to understand differences in visual function-related patient-reported outcomes between a non-BAK medication (Travoprost APS) and a BAK-preserved medication (XALATAN®) in patients with open-angle glaucoma or ocular hypertension.

Completed24 enrollment criteria

To Demonstrate the Relative Bioavailability of Atenolol Tablets

Hypertension

To demonstrate the relative bioavailability of Atenolol tablets.

Completed3 enrollment criteria

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups...

Hypertension

The initial 12 week portion of this 20 week study will examine the ability of a combination of olmesartan medoxomil and amlodipine to lower the blood pressure of patients with high blood pressure who have not had sufficient blood pressure reduction using one anti-hypertension drug (monotherapy). The final 8 weeks of this 20 week study will examine the ability of a combination of olmesartan medoxomil, amlodipine and hydrochlorothiazide to lower blood pressure in the same patient population. All three medications being tested have been approved by the FDA for the treatment of high blood pressure, but only amlodipine and olmesartan are currently approved for use in combination form.

Completed12 enrollment criteria
1...326327328...587

Need Help? Contact our team!


We'll reach out to this number within 24 hrs